(Q51362851)
Statements
1 reference
Canagliflozin improves glycaemic control over 28 days in subjects with type 2 diabetes not optimally controlled on insulin. (English)
1 reference
1 reference
D Devineni
1 reference
L Morrow
1 reference
D Skee
1 reference
A Vandebosch
1 reference
J Murphy
1 reference
K Ways
1 reference
S Schwartz
1 reference
8 February 2012
1 reference
14
1 reference
6
1 reference
539-545
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference